These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26686258)

  • 41. European health systems and cancer care.
    Micheli A; Coebergh JW; Mugno E; Massimiliani E; Sant M; Oberaigner W; Holub J; Storm HH; Forman D; Quinn M; Aareleid T; Sankila R; Hakulinen T; Faivre J; Ziegler H; Tryggvadòttir L; Zanetti R; Dalmas M; Visser O; Langmark F; Bielska-Lasota M; Wronkowski Z; Pinheiro PS; Brewster DH; Plesko I; Pompe-Kirn V; Martinez-Garcia C; Barlow L; Möller T; Lutz JM; André M; Steward JA
    Ann Oncol; 2003; 14 Suppl 5():v41-60. PubMed ID: 14684500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trends in net survival from cervical cancer in six European Latin countries: results from the SUDCAN population-based study.
    Haelens A; Roche L; Bastos J; Woronoff AS; Zorzi M; Francart J;
    Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S92-S99. PubMed ID: 28005611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study.
    Ritter AJ; Goldstein JS; Ayers AA; Flowers CR
    Leuk Lymphoma; 2019 Jul; 60(7):1656-1667. PubMed ID: 30632824
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study.
    Botta L; Gatta G; Capocaccia R; Stiller C; Cañete A; Dal Maso L; Innos K; Mihor A; Erdmann F; Spix C; Lacour B; Marcos-Gragera R; Murray D; Rossi S;
    Lancet Oncol; 2022 Dec; 23(12):1525-1536. PubMed ID: 36400102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Report on health status of residents in areas with industrial, mining or military sites in Sardinia, Italy].
    Biggeri A; Lagazio C; Catelan D; Pirastu R; Casson F; Terracini B
    Epidemiol Prev; 2006; 30(1 Suppl 1):5-95. PubMed ID: 16826748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role?
    Le Guyader-Peyrou S; Orazio S; Dejardin O; Maynadié M; Troussard X; Monnereau A
    Haematologica; 2017 Mar; 102(3):584-592. PubMed ID: 27909221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
    Wendum D; Sebban C; Gaulard P; Coiffier B; Tilly H; Cazals D; Boehn A; Casasnovas RO; Bouabdallah R; Jaubert J; Ferrant A; Diebold J; de Mascarel A; Gisselbrecht C
    J Clin Oncol; 1997 Apr; 15(4):1654-63. PubMed ID: 9193366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trends in net survival from ovarian cancer in six European Latin countries: results from the SUDCAN population-based study.
    Chirlaque MD; Uhry Z; Salmerón D; Sánchez-Zapata MI; Zannoni GF; Navarro C;
    Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S107-S113. PubMed ID: 28005613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spectrum of lymphoma subtypes based on the latest World Health Organization classification in southern Iran from 2000 to 2011.
    Samiee F; Mohammadi R; Shirian S; Alijani MR; Aledavood A; Negahban S; Ghaemi A; Daneshbod K; Daneshbod Y
    Future Oncol; 2021 Dec; 17(34):4733-4744. PubMed ID: 34756105
    [No Abstract]   [Full Text] [Related]  

  • 51. Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma.
    Keating GM
    Drugs; 2010 Jul; 70(11):1445-76. PubMed ID: 20614951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial.
    Xu PP; Fu D; Li JY; Hu JD; Wang X; Zhou JF; Yu H; Zhao X; Huang YH; Jiang L; Liu F; Su LP; Chen ZW; Zeng QS; Chen JP; Fang MY; Ma J; Liu T; Song YP; Yu K; Li Y; Qiu LG; Chen XQ; Gu J; Yan JS; Hou M; Huang HY; Wang L; Cheng S; Shen Y; Xiong H; Chen SJ; Zhao WL
    Lancet Haematol; 2019 Jun; 6(6):e328-e337. PubMed ID: 31126528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trends in net survival from esophageal cancer in six European Latin countries: results from the SUDCAN population-based study.
    Launoy G; Bossard N; Castro C; Manfredi S;
    Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S24-S31. PubMed ID: 28005602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends in net survival from liver cancer in six European Latin countries: results from the SUDCAN population-based study.
    Ferretti S; Bossard N; Binder-Fouchard F; Faivre J; Bordoni A; Biavati P; Frassoldati A;
    Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S56-S62. PubMed ID: 28005606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?
    Abdel-Rahman M; Stockton D; Rachet B; Hakulinen T; Coleman MP
    Br J Cancer; 2009 Dec; 101 Suppl 2(Suppl 2):S115-24. PubMed ID: 19956155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute.
    Garvin AJ; Simon RM; Osborne CK; Merrill J; Young RC; Berard CW
    Cancer; 1983 Aug; 52(3):393-8. PubMed ID: 6344979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas.
    Aggarwal N; Swerdlow SH; Kelly LM; Ogilvie JB; Nikiforova MN; Sathanoori M; Nikiforov YE
    Mod Pathol; 2012 Sep; 25(9):1203-11. PubMed ID: 22575864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Therapeutic results and evolution of Black African patients with follicular lymphoma: Ivory Coast experience].
    Koffi G; Kouakou B; Ndiaye FS; Ndathz E; Sanogo I; Sangare A
    Bull Cancer; 2007 Oct; 94(10):902-6. PubMed ID: 17964984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival of adults with cancers of bone or soft tissue in Europe-Report from the EUROCARE-5 study.
    Stiller CA; Botta L; Brewster DH; Ho VKY; Frezza AM; Whelan J; Casali PG; Trama A; Gatta G;
    Cancer Epidemiol; 2018 Oct; 56():146-153. PubMed ID: 30179828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Variation in survival of European children with acute lymphoblastic leukaemia, diagnosed in 1978--1992: the EUROCARE study.
    Coebergh JW; Pastore G; Gatta G; Corazziari I; Kamps W;
    Eur J Cancer; 2001 Apr; 37(6):687-94. PubMed ID: 11311642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.